Naoki Takegawa

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

Ken Kato, Yoshinori Ito, Hiroyuki Daiko et al. · Journal of Clinical Oncology · 2022 · 191 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +19

DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance

Naoki Takegawa, Yoshikane Nonagase, Kimio Yonesaka et al. · International Journal of Cancer · 2017 · 186 citations · Full text

Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial

Ken Kato, Ryunosuke Machida, Yoshinori Ito et al. · The Lancet · 2024 · 182 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +8

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity

Kimio Yonesaka, Koji Haratani, Shiki Takamura et al. · Clinical Cancer Research · 2018 · 160 citations

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai et al. · The Oncologist · 2020 · 93 citations · Full text